Article
Identification of 4 immune cells and a 5-lncRNA risk signature with prognosis for early-stage lung adenocarcinoma
26 Mar 2021
Abstract excerpt
BACKGROUND: Lung cancer is the most common cancer and cause of cancer-related mortality worldwide, increasing evidence indicated that there was a significant correlation between tumors and the long non-coding RNAs (lncRNAs), as well as tumor immune infiltration, but their role in early lung adenocarcinoma (LUAD) are still unclear. METHODS: Gene expression data and corresponding clinical data of early-stage LUAD...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
